Novel Therapies That May Cure Chronic Hepatitis B Virus

Clin Liver Dis. 2021 Nov;25(4):875-899. doi: 10.1016/j.cld.2021.07.001.

Abstract

The hepatitis B virus (HBV) is a member of the Hepadnaviridae family, which includes small DNA enveloped viruses that infect primates, rodents, and birds and is the causative factor of chronic hepatitis B. A common feature of all these viruses is their great specificity by species and cell type, as well as a peculiar genomic and replication organization similar to that of retroviruses. The HBV virion consists of an external lipid envelope and an internal icosahedral protein capsid containing the viral genome and a DNA polymerase, which also functions as a reverse transcriptase.

Keywords: Hepatitis B virus; Immunomodulators; Inhibitors of viral replication; New anti-HBV therapy; Viral antigen inbibitors; Viral replication Inhibitors; Viral replication cycle; cccDNA.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • DNA, Viral / genetics
  • Hepatitis B virus* / genetics
  • Hepatitis B, Chronic* / drug therapy
  • Humans
  • Virion
  • Virus Replication

Substances

  • DNA, Viral